Patients with lipedema alone, without metabolic comorbidities, may not benefit significantly from GLP-1 monotherapy
In mice, intracerebroventricular (ICV), intra-ventral tegmental area, and intra-dorsolateral tegmental area injections of ghrelin increased alcohol intake [12,13,14]
However, combined use requires medical supervision, individualized monitoring of hormone levels, blood counts, and cardiovascular parameters, and careful assessment of each medication's risk-benefit profile
and A.v.d.A
Theyre basically reinforcements for your gut on its slower schedule
Your healthcare provider will then increase the dose to 5 mg weekly, with potential further increases every four weeks (to 7.5 mg, 10 mg, 12.5 mg, or maximum 15 mg) based on your glycemic response, weight loss progress, and tolerability